Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Zbigniew Zegota Specjalistyczny Osrodek Leczniczo - Badawczy

Verified siteinfo

Poland Ulica Jana III Sobieskiego 3c 44, 14-100 Ostróda, Poland

  • Asthma · Chronic obstructive pulmonary disease
  • Adult patients

About Specializations

Zbigniew Zegota Specjalistyczny Osrodek Leczniczo - Badawczy in Ostróda, Poland specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Medicine

The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for conditions such as moderate-to-severe uncontrolled asthma. Through rigorous clinical trials, the center is dedicated to improving patient outcomes and enhancing quality of life for those affected by respiratory disorders.

  • Asthma Management
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interstitial Lung Disease

By conducting advanced research, the center contributes significantly to the development of new therapeutic strategies, offering hope to patients with challenging respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulica Jana III Sobieskiego 3c 4414-100 OstródaPoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
2
Partner status
Verified site

More sites in OstródaPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Chronic obstructive pulmonary disease

Not recruiting

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Chronic obstructive pulmonary disease

Not recruiting

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.